#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paroxysmal nocturnal haemoglobinuria Rosai-Dorfman syndrome Thalassaemia alpha Pulmonary sarcoidosis Hodgkin's disease refractory Glioblastoma Fms-like tyrosine kinase 3 positive Prophylaxis against transplant rejection Asthma Systemic mastocytosis Non-small cell lung cancer Precursor T-lymphoblastic lymphoma/leukaemia recurrent Pemphigoid Small intestine adenocarcinoma Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Diagnostics Breast angiosarcoma metastatic Shprintzen-Goldberg syndrome – Trials in Disease Idiopathic inflammatory myopathy – Treatment SAPHO syndrome – Diagnostics Toxic epidermal necrolysis – Diagnostics Chronic granulomatous disease – Treatment Gaucher’s disease type III – Basic Information Haemophilia A with anti factor VIII Alagille syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diclofenac Diethylamine HYALURONIDASE ALE.P03 Midostaurin Dutasteride Olopatadine Metformin Hydrochloride Anhydrous Docetaxel [11C]Az14193391 Dextrose Bp Mirtazapine Alogliptin Azd2693 Sodium Oric-114 VOXVOGANAN Deucrictibant Cemiplimab Nepafenac Diazepam Lisdexamfetamine Dimesylate More therapies…

    Learn about Your Condition

    Hepatic encephalopathy Loeys-Dietz syndrome Testicular germ cell cancer Anal incontinence Eye pain Oxygen therapy Retinal neovascularisation Mumps Ureteric cancer Bronchiolitis Bone hypertrophy Haemorrhoids Acute hepatic failure Factor IX deficiency Adenosquamous cell lung cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lung squamous cell carcinoma stage IV

  • Study on the Effect of Ivonescimab, Pemetrexed, and Carboplatin in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation After Previous Treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pemetrexed Disodium
    • Carboplatin
    • Ivonescimab
    France Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!